Literature DB >> 2605098

A novel hybridoma antibody (PASE/4LJ) to human prostatic acid phosphatase suitable for immunohistochemistry.

A M Haines1, S E Larkin, A P Richardson, R W Stirling, E Heyderman.   

Abstract

A murine monoclonal antibody PASE/4LJ to prostatic acid phosphatase (PAP) was used to immunostain a wide variety of sections of benign and malignant tissues (654 blocks). Non-neoplastic adult and fetal prostatic glands, primary and metastatic prostatic carcinomas, and scattered cells in prostatic and penile urethra were positive. Rat, dog and rabbit prostates were negative. Nine of 400 tumours of non-prostatic origin showed some positivity: 6/36 carcinoids, 1/9 islet cell tumours, 1/55 ovarian adenocarcinomas (serous) and one carcinosarcoma of the lung (epithelial portion). Positive staining was seen in islet cells in 4/5 specimens of normal pancreas, and in 4/9 blocks of normal pancreas surrounding a pancreatic tumour. Loops of Henle, maculae densae, and distal tubules in 10/10 fetal and 2/9 adult kidneys were also positive, with proximal tubules and collecting ducts negative. All other 159 blocks of non-neoplastic adult and fetal tissues were negative. The antibody was also affinity purified from ascitic fluid, and shown not to inhibit the enzyme activity of prostatic acid phosphatase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2605098      PMCID: PMC2247265          DOI: 10.1038/bjc.1989.385

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Properties of the avid phosphatases of erythrocytes and of human prostate gland.

Authors:  M A M ABUL-FADL; E J KING
Journal:  Biochem J       Date:  1949       Impact factor: 3.857

3.  Expression of human prostatic acid phosphatase in a pancreatic islet cell carcinoma.

Authors:  B K Choe; E J Pontes; N R Rose; M D Henderson
Journal:  Invest Urol       Date:  1978-01

4.  A homogeneous isoenzyme of human liver acid phosphatase.

Authors:  M S Saini; R L Van Etten
Journal:  Arch Biochem Biophys       Date:  1978-12       Impact factor: 4.013

5.  Demonstration of the prostatic origin of metastases: an immunohistochemical method for formalin-fixed embedded tissue.

Authors:  A C Jöbsis; G P De Vries; R R Anholt; G T Sanders
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

6.  Prostatic acid phosphatase in tissue sections revealed by the unlabelled antibody peroxidase-antiperoxidase method.

Authors:  J Burns
Journal:  Biomedicine       Date:  1977-01-31

7.  Studies of acid phosphatase isoenzymes in human leukocytes demonstration of isoenzyme cell specificity.

Authors:  C Y Li; L T Yam; K W Lam
Journal:  J Histochem Cytochem       Date:  1970-12       Impact factor: 2.479

8.  Immunohistochemical diagnosis of prostatic cancer with metastasis.

Authors:  C Y Li; W K Lam; L T Yam
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

9.  Purification of a human prostate specific antigen.

Authors:  M C Wang; L A Valenzuela; G P Murphy; T M Chu
Journal:  Invest Urol       Date:  1979-09

10.  Preparation of homogeneous human prostatic acid phosphatase using concanavalin A-sepharose 4-B.

Authors:  R L Van Etten; M S Saini
Journal:  Biochim Biophys Acta       Date:  1977-10-13
View more
  7 in total

Review 1.  The Effect of Targeted Therapy for Genitourinary Malignancies on Sexual Function and Fertility.

Authors:  Bradley C Holland; Zubin Shetty; Shaheen Alanee
Journal:  Curr Urol Rep       Date:  2017-08       Impact factor: 3.092

2.  Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologists.

Authors:  Jorge A Garcia
Journal:  Ther Adv Med Oncol       Date:  2011-03       Impact factor: 8.168

Review 3.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

4.  Prostatic acid phosphatase expression in human tissues.

Authors:  Thomas J Graddis; Catherine J McMahan; Jennifer Tamman; Keith J Page; James B Trager
Journal:  Int J Clin Exp Pathol       Date:  2011-03-22

5.  Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2.

Authors:  E Heyderman; S E Larkin; P J O'Donnell; A M Haines; P J Warren; A Northeast; A G Grant
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

6.  Prostatic-like acid phosphatase in human endometrial glands and its cyclic activity.

Authors:  Seppo Edvin Partanen
Journal:  J Mol Histol       Date:  2007-10-12       Impact factor: 2.611

7.  Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer.

Authors:  Nadeem A Sheikh; Daniel Petrylak; Philip W Kantoff; Corazon Dela Rosa; Frances P Stewart; Ling-Yu Kuan; James B Whitmore; James B Trager; Christian H Poehlein; Mark W Frohlich; David L Urdal
Journal:  Cancer Immunol Immunother       Date:  2012-08-03       Impact factor: 6.968

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.